Internist and lipidologist at University of Pennsylvania. Aging soccer player. Dad and husband. President National Lipid Association (2023/24)
Joined June 2015
- Tweets 2,657
- Following 587
- Followers 1,314
- Likes 3,430
134 Photos and videos
Dan Soffer retweeted
1 Oct 2024
#OriginalResearch Both 'weekend warrior' and regular exercise patterns lower cardiometabolic risk. The total volume of physical activity, rather the pattern is most relevant for risk of future disease. @ShinoKany @shaan_khurshid ahajournals.org/doi/abs/10.1…
32
92
19,239
Dan Soffer retweeted
2 Oct 2024
A timely symposium on Racial Disparities in Cardiovascular Disease Risk sponsored by @UABCardiology
Honored to be invited
My talk will be on ‘Race and cardiovascular risk. Is it genes or environment?’
1 Oct 2024
Session 2: Racial Disparities in Cardiovascular Disease Risk
Iftikhar J. Kullo, MD - Mayo Clinic
Topic: Race and cardiovascular risk. Is it genes or
environment?
Time: 10:35 - 11:00 AM
5
23
2,284
Dan Soffer retweeted
7 Aug 2024
Save these dates for #EpiLifestyle25! New Orleans is the place to be for insightful discussions, leading epidemiology and lifestyle science, and networking with colleagues old and new.
6
14
4,349
Dan Soffer retweeted
18 Sep 2024
Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System. @dan_soffer
authors.elsevier.com/a/1jn5T…
5
16
2,579
Dan Soffer retweeted
24 Sep 2024
Real-world experience of inclisiran at UPenn, now in JCL: authors.elsevier.com/a/1jpv%…
@dan_soffer @MWilkinsonMD
1
3
396
Dan Soffer retweeted
Join us for Beyond the Basics: Approach to Lipoprotein(a) Management, a complimentary dinner program with CVI and PLAC! October 16, at the Loews Philadelphia Hotel. tinyurl.com/6ym2jve9
4
8
827
Dan Soffer retweeted
13 Sep 2024
In this @medscapeCME, #CardioRheumatology experts Dr. Michael Garshick and Dr. Brittany Weber share insights on assessing inflammatory risk and the latest treatments to improve outcomes for patients at risk of cardiovascular events.
@nyugrossman @RobMagyar @garshick @Bweber04
11 Sep 2024
Identifying residual inflammatory risk is crucial for developing targeted treatments to reduce future CV events and manage atherosclerosis more effectively!
Watch @garshick @Bweber04 explain the ASCVD / inflammation / CKD nexus 👉 ms.spr.ly/6010m3kok
6
17
3,144
16 Sep 2024
Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System, JCL in press.
kwnsfk27.r.eu-west-1.awstrac…
3
2
19
1,391
16 Sep 2024
Now available @nationallipid @MarlysLPA @MBBoffa @Lpa_Doc @hillypaige2 @PennCVFellows @PennCardiology @ProfKausikRay @JohnKastelein @ArsenaultBenoit @Drlipid
4
339
Dan Soffer retweeted
13 Sep 2024
Thanks Dr. Kulkarni for the opportunity. It’s always fun to write about lipids :)
13 Sep 2024
So proud of my superstar fellow @PriyaPillaiMD of @HeartPlano for expertly curating this Tweetorial on dietary habits! Please be sure to check it out!
@PSatishMD @carolkirkpat3 @AnumSaeedMD @amehta_09 @LipidCNS @nationallipid
1
2
343
Dan Soffer retweeted
14 Sep 2024
📄#SourceSaturday: Our Practical Recommendations in the Management of CV Diseases
Check out this easy breakdown!
🔗Download the infographic ow.ly/ZyaE50TnaFA
#LipidXcellence #CholesterolMonth
3
9
872
Dan Soffer retweeted
12 Sep 2024
We’re just 10 DAYS away from thought-provoking sessions and impactful discussion at the #FamilyHeartSummit24. Wave hi if we’ll see you there! 👋
1
2
361
Dan Soffer retweeted
I have had the pleasure of working with @TinaKReddy and team to highlight the importance of public health measures and team-based care in addressing the disproportionate burden of resistant hypertension in US Black adults. See our article here!
link.springer.com/article/10…
2
14
713
Dan Soffer retweeted
12 Sep 2024
Lipidaholics - just what you are all waiting for - another podcast of yours truly - this time interviewed by a pharmacist, Dr Tamara Ruggles - As usual I had a lot of fun - Visit and hopefully enjoy at https:// pharmacypodcastnetwork.podbe… @nationallipid @society_eas @escardio @atherosociety @TheFHFoundation
2
7
39
3,716
Dan Soffer retweeted
12 Sep 2024
Anne Langsted and I wrote a quick and comprehensive ABC on "Lipoprotein(a) and cardiovascular disease", just published in The Lancet: thelancet.com/journals/lance…
As 1 in 5 have this the most common genetic cause of CVD, it is high time to measure in all at CVD risk. Treatment soon:
10
59
169
23,406
Dan Soffer retweeted
12 Sep 2024
@nationallipid recently made recommendations to consider lipoprotein apheresis in certain patients with elevated Lp(a):
sciencedirect.com/science/ar…
@MarlysLPA @MBBoffa @kcferdmd @ErinMichos @DrSafarova @dan_soffer @PamTaubMD @CBallantyneMD @grsoffer @hsbhatia @DrMichaelShapir
3
9
23
920
Dan Soffer retweeted
12 Sep 2024
Lp(a) is actionable today, & for some patients this includes treatment with lipoprotein apheresis
link.springer.com/article/10…
@MBBoffa @MarlysLPA @kcferdmd @ErinMichos @DrSafarova @nationallipid @ASPCardio @dan_soffer @CBallantyneMD @PamTaubMD @DrMichaelShapir @lipiddoc @UCSDHealth
4
11
546
Dan Soffer retweeted
9 Sep 2024
Dear Twitter/X, thank you for noticing our apoB paper. In an effort to release it coincident with our Fall CLU, the infographic draft was inadvertently released. Please keep an eye out for the final product and apologies for the miscommunication. Thanks for the feedback!
4
9
3,625
5 Sep 2024
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association - Journal of Clinical Lipidology lipidjournal.com/article/S19…
9
46
3,266
Dan Soffer retweeted
1 Sep 2024
📚#SpotlightSunday
Dive into the essentials w/ the 2018 Guidelines for Managing Blood Cholesterol
They provide clear, actionable steps to manage cholesterol levels & reduce CV risk in your patients
Read the guidelines🔗ow.ly/wuZK50TaZfQ
#LipidXcellence #CholesterolMonth
1
1
4
805